Clinical Scorecard: Correction to the Funding and Support Information
At a Glance
| Category | Detail |
|---|---|
| Condition | Primary progressive aphasia (PPA), including clinical, anatomical, and pathological variants |
| Key Mechanisms | Not described; the correction concerns funding attribution for an automated speech analysis investigation. |
| Target Population | Not specified in the correction. |
| Care Setting | Research context: automated speech analysis in PPA; clinical care setting is not specified. |
Key Highlights
- The correction addresses the Funding/Support statement of an Original Investigation on automated speech analysis in PPA.
- Dr Vonk’s NIH support was attributed to grants R00AG066934 and RF1AG091509.
- Dr Gorno-Tempini’s NIH support was attributed to grants R01NS050915, K24DC015544, and R01AG075775.
- P01AG019724 supported Drs Gorno-Tempini, Rosen, and Seeley; U19AG063911 supported Dr Rosen.
- Dr Henry’s support included NIH/NIDCD grant R01DC016291; Dr Vonk’s support also included a 2025 UCSF Catalyst Award.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Not reported in the correction.
No treatment or prescribing information is provided.
Clinical Best Practices
Related Resources & Content
Based on findings from:
Error in Funding/Support
Jama Neurology, 2026.
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854367
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
